Target intelligence / Profile preview

Platelet 47 kDa type III collagen receptor (p47)

Target
p47
Molecular classification
Receptor, Other
01

Overview

The Platelet 47 kDa type III collagen receptor, often referred to as p47, is a non-integrin membrane protein that specifically mediates the interaction between platelets and type III collagen (Chiang et al., 1993). This receptor is distinct from other major collagen receptors like GPVI and integrin alpha2beta1, and it plays a crucial role in the initial stages of platelet adhesion and activation upon vascular injury (Chiang et al., 2002). Research has characterized this 47 kDa protein as a specific receptor for type III collagen, which is abundant in the subendothelial matrix and triggers intracellular signaling pathways, including protein tyrosine phosphorylation, leading to platelet aggregation and thrombus formation (Chiang et al., 2002). Some evidence suggests that this receptor may be identical or closely related to Heat Shock Protein 47 (HSP47), a collagen-specific chaperone that is also expressed on the platelet surface and promotes adhesion (Sasikumar et al., 2018). Experimental inhibitors, such as the small molecule Col003 and specific sequence-derived peptides, have demonstrated the ability to block type III collagen-induced platelet activation in vitro and in animal models (Ito et al., 2017; Chiang et al., 2002). Consequently, the receptor is considered a potential therapeutic target for the development of selective antithrombotic drugs that may offer a lower bleeding risk than conventional antiplatelet agents.

Other names
p47Platelet receptor for type III collagenPlatelet 47 kDa collagen receptorColiginHeat shock protein 47 (potential identity)HSP47 (potential identity)
02

Mechanism of action

Inhibition of platelet adhesion and aggregation by blocking the interaction between the receptor and type III collagen.

03

Biological functions

Signal transductionCell adhesionOther
04

Disease associations

Cardiovascular diseaseOther
05

Safety considerations

Bleeding riskInterference with normal hemostasis
06

Interacting drugs

Col003

2 more in the full profile.

07

Biomarkers

Platelet aggregation response to type III collagenSurface expression of p47

Beyond the preview

Go deeper on Platelet 47 kDa type III collagen receptor (p47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Platelet 47 kDa type III collagen receptor (p47).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call